Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001206774-07-002439
Filing Date
2007-10-23
Accepted
2007-10-23 15:26:34
Documents
6
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT - AMENDMENT avigen_10ka.htm 10-K/A 1078636
2 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO. LLP, INDEPENDENT REGISTERED PUBLI exhibit_23-1.htm EX-23.1 2342
3 CONSENT OF ERNST & YOUNG LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM exhibit_23-2.htm EX-23.2 2112
4 CEO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit_31-1.htm EX-31.1 2375
5 CFO CERTIFICATION REQUIRED BY RULE 13A-14(A) OR RULE 15D-14(A) exhibit_31-2.htm EX-31.2 2389
6 CERTIFICATION REQUIRED BY RULE 13A-14(B) OR RULE 15D-14(B) AND SECTION 1350 OF exhibit_32-1.htm EX-32.1 3763
  Complete submission text file 0001206774-07-002439.txt   1093029
Mailing Address 1301 HARBOR BAY PARKWAY ALAMEDA CA 94502
Business Address 1301 HARBOR BAY PARKWAY . ALAMEDA CA 94502 5107487150
AVIGEN INC \DE (Filer) CIK: 0000932903 (see all company filings)

EIN.: 133647119 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-28272 | Film No.: 071185597
SIC: 2835 In Vitro & In Vivo Diagnostic Substances